Compassionate-use lurbinectedin demonstrates modest yet consistent efficacy and is well tolerated in patients with ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

A new trial finds guselkumab is highly effective and well tolerated for moderate to severe scalp psoriasis in individuals ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the ARTIST study, an RCT evaluating ...

An ongoing Phase III clinical trial of DengiAll, a one-shot dengue vaccine developed by Panacea Biotec, is progressing in ...

One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.

Carmelo D'Agostino, a researcher in traffic safety and behaviour, and stem cell researcher Paul Bourgine receive ERC Proof of Concept grants for their ...

Data from three independent clinical studies demonstrate utility of tafenoquine to treat acute canine babesiosis; WASHINGTON, July 14, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmace ...

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

Sotatercept-csrk was first approved in 2024 to treat pulmonary arterial hypertension (PAH) in adults based on results seen in the phase 3 STELLAR trial.